12
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Receptor Binding and Biological Activity of IL-α, IL-1β, IL-1β Analogues and an IL-1 Antagonist in A375 Human Melanoma Cells

, , , , , & show all
Pages 245-262 | Published online: 26 Sep 2008

References

  • Lachman L. B., Dinarello C. A., Llansa N. D., Fidler I. J. Natural and recombinant human interleukin 1–β is cytotoxic for human melanoma cells. J. Immunol. 1986; 136: 3098–3102
  • Sims J. E., March C. J., Cosman D., Widmer M. D., Mac Donald H. R., Grubin C. E., Wignall J. M., Call S. M., Friend D., Alpert A. R., Gillis S., Urdal S., Dower S. K. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 1988; 241: 585–589
  • Sims J. E., Acres R. B., Grubin C. E., McMahon C. J., Wignall J. M., March C. J., Dower S. K. Cloning of the interleukin-1 receptor from human T-cells. Proc. Natl. Acad. Sci. USA 1989; 86: 8946–8950
  • McMahan C. J., Slack J. L., Mosley B., Cosman D., Lupton S. D., Brunton S. L., Grubin C. E., Wignall J. M., Jenkins N. A., Brannan C. I., Copeland N. G., Huebner K., Croce C. M., Cannizzarro L. A., Benjamin D., Dower S. K., Spriggs M. K., Sims J. E. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 1991; 10: 2821–2832
  • Endo Y., Matsushima K., Oppenheim J. J. Mechanism of in vitro antitumor effects of interleukin 1 (IL-1). Immunobiology 1986; 172: 316–322
  • Usui N., Mimmaugh E. G., Sinha B. K. A role for the interleukin 1 receptor in the synergistic antitumor effects of human interleukin 1α and etoposide against human melanoma cells. Cancer Res. 1991; 51: 769–774
  • Priestle J. P., Schär H.-P., Grütter M. G. Crystallographic refinement of interleukin 1β at 2.0 A resolution. Proc. Natl. Acad. Sci. USA 1989; 86: 9667.9671
  • Labriola-Tompkins E., Chandran C., Kaffka K. L., Biondi D., Graves B. J., Hatada M., Madison V. S., Karas J., Kilian P. L., Ju G. Identification of the discontinuous binding site in human interleukin 1β for the type I interleukin 1 receptor. Proc. Natl. Acad. Sci. USA 1991; 88: 11182–11186
  • Van Oostrum J., Priestle J. P., Grütter M. G., Schmitz A. The structure of murine interleukin-1β at 2.8 A resolution. J. Struct. Biol. 1991; 107: 189–195
  • Dower S. K., Kronheim S. R., Hopp T. P., Cantrell M., Deeley M. C., Gillis S., Henney C. S., Urdal D. L. The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical. Nature 1986; 324: 266–267
  • Siegrist W., Solca F., Stutz S., Giuffrè L., Carrel S., Girard J., Eberle A. N. Characterization of receptors for α-melanocyte stimulating hormone on human melanoma cells. Cancer Res. 1989; 49: 6352–6358
  • Munson P. G., Rodbard D. A versatile computerized approach for characterization of ligand-binding systems. Analyt. Biochem. 1980; 107: 220–239
  • Nakai S., Mizuno K., Kaneta M., Hirai Y. A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma cells. Biochem. Biophys. Res. Comm. 1988; 154: 1189–1196
  • Lowcnthal J. W., McDonald H. R. Binding and internalisation of interleukin-1 by T cells: direct evidence for high- and lowaffinity classes of interleukin-1 receptor. J. Exp. Med. 1986; 164: 1060–1074
  • Dower S. K., Urdal D. L. The interleukin-1 receptor. Immunol. Today 1987; 8: 46–51
  • Lovett D., Kozan B., Hadam M., Resch K., Gemsa D. Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis. J. Immunol. 1986; 136: 340–347
  • Ju G., Labriola-Tomkins E., Campen C. A., Benjamin W. R., Karas J., Plocinski J., Biondi D., Kaffka K. L., Kilian P. L., Eisenberg S. P., Evans R. J. Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis. Proc. Natl. Acad. Sci, USA 1991; 88: 2658–2662
  • Gehrke L., Jobling S. A., Paik L. S., McDonald B., Rosen-Wasser L. J., Auron P. E. A point mutation uncouples human interleukin-1 beta biological activity and receptor binding. J. Biol. Chem. 1990; 265: 5922–5925
  • Dinarello C. A., Thompson R. C. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol. Today 1991; 12: 404–410

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.